CARE Ratings Q4 FY26: Revenue Up 18% to ₹130.67 Cr, PAT Grows 23%
CARE Ratings reported Q4 FY26 consolidated revenue of ₹130.67 crore (up 19% YoY) and PAT of ₹53.45 crore (up 23% YoY). FY26 consolidated revenue reached ₹473.07 crore (up 18% YoY) with PAT at ₹173.69 crore (up 24% YoY). The Board recommended a final dividend of ₹14 per share.
The announcement includes detailed financial results for the quarter and full year, dividend declaration, and commentary from the MD & CEO, which are material information for investors and stakeholders.
The company reported strong year-on-year growth in revenue and profit for both the quarter and the full financial year, along with a recommended dividend, indicating positive financial performance.
CARE Ratings Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a consolidated revenue from operations of ₹130.67 crore for Q4 FY26, an increase of 19% year-on-year. For the full financial year FY26, consolidated revenue from operations stood at ₹473.07 crore, up 18% year-on-year.
Consolidated Profit After Tax (PAT) for Q4 FY26 was ₹53.45 crore, a growth of 23% year-on-year, with a PAT margin of 37%. For FY26, consolidated PAT was ₹173.69 crore, an increase of 24% year-on-year, and a PAT margin of 33%.
On a standalone basis, revenue from operations for Q4 FY26 was ₹107.58 crore, up 18% year-on-year. Standalone PAT for Q4 FY26 was ₹53.39 crore, up 19% year-on-year, with a PAT margin of 43%. For FY26, standalone revenue was ₹387.72 crore (up 15% YoY) and standalone PAT was ₹174.39 crore (up 18% YoY), with a PAT margin of 39%.
Mehul Pandya, Managing Director & Group CEO of CareEdge, commented that the performance reflects the franchise's strength and operational efficiencies. He highlighted the growth in standalone revenue driven by initial ratings and the increased contribution from non-ratings and overseas businesses at the consolidated level. The company also noted the successful debut of the Past Risk and Verification Agency (PaRRVA), a regulatory initiative conceptualized by SEBI and built in collaboration with CareEdge Ratings and NSE.
The Board of Directors has recommended a final dividend of ₹14 per share, bringing the total dividend for the year to ₹22 per share.
What to do with a filing like this
CARE Ratings Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CARE Ratings Limited. Read the original for the full detail.